It has been two weeks since South Africa reported the COVID-19 Omicron variant to the World Health Organization (WHO).
While the world worries that the Omicron variant may cause a surge of cases, drug developers on the other hand have some hopeful news with new antiviral pills coming soon, expected to work against all strains of the virus, and treatments intended for long-term prevention against COVID-19 infection.
The latest updates on these hot-button issues, along with all the information you need on:
✅ the COVID-19 variants and the vaccines’ effectiveness
✅ the progress of COVID-19 vaccinations in major regions of the world
✅ leading COVID-19 vaccines and vaccine candidates in clinical trial development, and
✅ the current landscape of novel treatments for COVID-19
are featured in the December Issue of the TIF ‘COVID-19 Vaccinations & Therapeutic Drugs Guide‘, which has just been released!